Who is sponsoring NCT03137641?

NCT03137641 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT03137641?

Interventions in NCT03137641: Nurses urine samples.

What condition does NCT03137641 study?

NCT03137641 studies Antineoplastic Drugs Contamination Prevalence.

Is NCT03137641 still recruiting?

NCT03137641 is currently completed. Last updated 15 May 2020.

Last reviewed 2020-05-15 · How we verify

NCT03137641: CACIES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nurses Internal Contamination by Antineoplastic Drugs.

Completed Last updated 15 May 2020

What this trial tests

trial testing Nurses urine samples in Antineoplastic Drugs Contamination Prevalence in 72 participants. Completed in 31 October 2019.

Timeline

16 October 2017

Primary endpoint
31 October 2019

31 October 2019

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	16 October 2017
Primary completion	31 October 2019
Estimated completion	31 October 2019
Sites	3 locations across France

Drugs / interventions tested

Nurses urine samples

Conditions studied

Antineoplastic Drugs Contamination Prevalence — all drugs for Antineoplastic Drugs Contamination Prevalence →

Sponsor

University Hospital, Bordeaux

Who can join

Eligibility, any sex, with Antineoplastic Drugs Contamination Prevalence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CACIES is a descriptive study conducted in two hospital centers in France to assess nurses internal contamination by antineoplastic drugs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.
Villa A, Molimard M, Bignon E, Martinez B, et al · · 2019 · cited 4× · PMID 31712349 · DOI 10.1136/bmjopen-2019-033040

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03137641 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 15 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03137641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing